Projects

Evaluation of a rapid ELFA method for detection of Anti-CHIKV IgM antibodies in patients with clinically suspected Chikungunya infection

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2024 - Ongoing

Project Lead

Ms. Sonika Mynahalli

Authors

Ms. Iliza T Kiba, Dr. Supriya Gachinmath, Dr. Sneha May Kurian,Dr. Lonika Lodha, Ms. Sonika Mynahalli

Project Status

completed

Project Type

Validational study